$KE

Kimball Electronics, Inc.

No enriched coverage for $KE in the last 7 days.

No SEC Form 4 filings for $KE in the last 30 days.

See all $KE insider activity →
Med

Kimball Electronics (KE) Bets Big On Medical Devices And Debt Paydown

Kimball Electronics (KE) reported Q4 net sales of $371.6M, up 5% sequentially. Full-year sales fell 4% to $1.431B. The company expects fiscal 2027 sales of $1.535B-$1.56B, driven by medical device growth and a recent acquisition. Debt reduced to $116.6M, with $88.9M in cash. Guidance includes flat to lower margins despite higher capital spending.

Q2 Rundown: Verra Mobility (NASDAQ:VRRM) Vs Other Electrical Systems Stocks

Powell (POWL) reported Q2 revenue of $311.7M, up 8.9% YoY but missing estimates, with stock down 17%. Kimball Solutions (KE) reported $371.6M revenue, down 2.3% YoY, missing EPS estimates. GE Vernova (GEV) reported $11.1B revenue, up 21.9% YoY, topping estimates but missing EPS. All companies provided full-year guidance.

Should You Buy Kimball Electronics Stock After Lackluster Q4 Results?

Kimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.

KE sentiment & insider activity

Recent KE coverage spans financial news and earnings.

What's driving KE

AlphAI scores every news story that mentions KE with an AI model for sentiment and relevance, and aggregates insider trades from Kimball Electronics, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KE

Score
$KEMedAI 8/10

Kimball Electronics (KE) Bets Big On Medical Devices And Debt Paydown

Kimball Electronics (KE) reported Q4 net sales of $371.6M, up 5% sequentially. Full-year sales fell 4% to $1.431B. The company expects fiscal 2027 sales of $1.535B-$1.56B, driven by medical device growth and a recent acquisition. Debt reduced to $116.6M, with $88.9M in cash. Guidance includes flat to lower margins despite higher capital spending.

$KEMed

Should You Buy Kimball Electronics Stock After Lackluster Q4 Results?

Kimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.

$KELow

Kimball Electronics (KE) awards Hass 13,831 restricted shares

Kimball Electronics (KE) officer Douglas Hass received 13,831 restricted shares and 3,422 performance-based shares on August 24, 2026. 12,132 restricted shares vested, with 6,751 shares withheld for taxes. New grants will vest in 2027, 2028, and 2029. Hass's total holdings include 32,157 restricted shares and 29,050 common shares.

$KELow

Kimball Electronics (Ticker: KE) grants CAO 3,849 shares

Kimball Electronics (KE) reported that its Chief Accounting Officer, Adam M. Baumann, received 3,849 restricted shares on August 24, 2026. Additionally, 2,438 restricted shares and 1,202 performance-based shares vested. To cover tax obligations, 1,533 shares were withheld at $22.725 per share. Baumann also holds 1,532 shares indirectly through a retirement fund.

Related tickers